124 related articles for article (PubMed ID: 9208874)
41. Human interferon-alpha receptor: identification of the region involved in binding to interferon-alpha B.
Hirata MH; Sackett D; Hirata RD; Nguyen NY
J Interferon Cytokine Res; 1996 Oct; 16(10):845-52. PubMed ID: 8910770
[TBL] [Abstract][Full Text] [Related]
42. Comparison of the in vitro host range of recombinant met-interferon-con1, interferon-alpha 2b, and interferon-beta [corrected].
Hu CJ; Ozes ON; Klein SB; Blatt LM; Taylor MW
J Interferon Cytokine Res; 1995 Mar; 15(3):231-4. PubMed ID: 7584668
[TBL] [Abstract][Full Text] [Related]
43. Cell surface binding characteristics correlate with consensus type I interferon enhanced activity.
Klein SB; Blatt LM; Taylor MW
J Interferon Cytokine Res; 1996 Jan; 16(1):1-6. PubMed ID: 8640445
[TBL] [Abstract][Full Text] [Related]
44. Analysis of an interaction between the soluble vaccinia virus-coded type I interferon (IFN)-receptor and human IFN-alpha1 and IFN-alpha2.
Liptáková H; Kontseková E; Alcamí A; Smith GL; Kontsek P
Virology; 1997 May; 232(1):86-90. PubMed ID: 9185591
[TBL] [Abstract][Full Text] [Related]
45. Progress toward the understanding of the molecular mechanisms of interferon action.
Samuel CE
Prog Clin Biol Res; 1987; 246():209-20. PubMed ID: 2443930
[TBL] [Abstract][Full Text] [Related]
46. Cloning, expression and antiviral activity of mink alpha-interferons.
Zhang HL; Zhao JJ; Chai XL; Zhang L; Bai X; Hu B; Liu H; Zhang DL; Ye M; Wu W; Yan XJ
BMC Vet Res; 2015 Feb; 11():42. PubMed ID: 25889984
[TBL] [Abstract][Full Text] [Related]
47. Two interferons alpha influence each other during their interaction with the extracellular domain of human type interferon receptor subunit 2.
Schmeisser H; Gorshkova I; Brown PH; Kontsek P; Schuck P; Zoon KC
Biochemistry; 2007 Dec; 46(50):14638-49. PubMed ID: 18027911
[TBL] [Abstract][Full Text] [Related]
48. Analysis of the antiviral activities of natural IFN-alpha preparations and their subtype compositions.
Yanai Y; Sanou O; Kayano T; Ariyasu H; Yamamoto K; Yamauchi H; Ikegami H; Kurimoto M
J Interferon Cytokine Res; 2001 Oct; 21(10):835-41. PubMed ID: 11710996
[TBL] [Abstract][Full Text] [Related]
49. Vaccinia virus protein B18R inhibits the activity and cellular binding of the novel type interferon-delta.
Vancová I; La Bonnardiere C; Kontsek P
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1647-9. PubMed ID: 9680126
[TBL] [Abstract][Full Text] [Related]
50. Different relative activities of human cell-derived interferon-alpha subtypes: IFN-alpha 8 has very high antiviral potency.
Foster GR; Rodrigues O; Ghouze F; Schulte-Frohlinde E; Testa D; Liao MJ; Stark GR; Leadbeater L; Thomas HC
J Interferon Cytokine Res; 1996 Dec; 16(12):1027-33. PubMed ID: 8974005
[TBL] [Abstract][Full Text] [Related]
51. Interferon is a polypeptide hormone.
Faltynek CR; Baglioni C
Microbiol Sci; 1984 Jul; 1(4):81-5. PubMed ID: 6086078
[TBL] [Abstract][Full Text] [Related]
52. Antagonist peptides of human interferon-alpha2b isolated from phage display library inhibit interferon induced antiviral activity.
Tian W; Bai G; Li ZH; Yang WB
Acta Pharmacol Sin; 2006 Aug; 27(8):1044-50. PubMed ID: 16867257
[TBL] [Abstract][Full Text] [Related]
53. In vitro sensitivity of human metapneumovirus to type I interferons.
Scagnolari C; Trombetti S; Selvaggi C; Carbone T; Monteleone K; Spano L; Di Marco P; Pierangeli A; Maggi F; Riva E; Antonelli G
Viral Immunol; 2011 Apr; 24(2):159-64. PubMed ID: 21449726
[TBL] [Abstract][Full Text] [Related]
54. Development and biological activity of long-acting recombinant human interferon-α2b.
Zhang Q; Wang C; Ma F; Yao L; Gao H; Zhu L; Zheng L
BMC Biotechnol; 2020 Mar; 20(1):16. PubMed ID: 32169063
[TBL] [Abstract][Full Text] [Related]
55. [SEM studies on IFN-receptor dynamics of cultured cells from mammals].
Augsten K; Unger E; Tonew M; Wollweber L; Noll F
Acta Histochem Suppl; 1990; 39():311-7. PubMed ID: 2150447
[TBL] [Abstract][Full Text] [Related]
56. Bovine type I interferon receptor protein BoIFNAR-1 has high-affinity and broad specificity for human type I interferons.
Langer JA; Yang J; Carmillo P; Ling LE
FEBS Lett; 1998 Jan; 421(2):131-5. PubMed ID: 9468293
[TBL] [Abstract][Full Text] [Related]
57. Human IFN-alpha protein engineering: the amino acid residues at positions 86 and 90 are important for antiproliferative activity.
Hu R; Bekisz J; Schmeisser H; McPhie P; Zoon K
J Immunol; 2001 Aug; 167(3):1482-9. PubMed ID: 11466368
[TBL] [Abstract][Full Text] [Related]
58. The combination of IFN-alpha2 and IFN-alpha8 exhibits synergistic antiproliferative activity on renal cell carcinoma (RCC) cell lines through increased binding affinity for IFNAR-2.
Tanimoto T; Yamamoto S; Taniai M; Taniguchi M; Ariyasu H; Ushio C; Aga M; Mukai Y; Tsutsumi Y; Ariyasu T; Ohta T; Fukuda S
J Interferon Cytokine Res; 2007 Jun; 27(6):517-23. PubMed ID: 17572016
[TBL] [Abstract][Full Text] [Related]
59. Biophysical analysis of the interaction of human ifnar2 expressed in E. coli with IFNalpha2.
Piehler J; Schreiber G
J Mol Biol; 1999 May; 289(1):57-67. PubMed ID: 10339405
[TBL] [Abstract][Full Text] [Related]
60. Field production and functional evaluation of chloroplast-derived interferon-alpha2b.
Arlen PA; Falconer R; Cherukumilli S; Cole A; Cole AM; Oishi KK; Daniell H
Plant Biotechnol J; 2007 Jul; 5(4):511-25. PubMed ID: 17490449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
